RxDoctor Payments Data

Kimberly Blackwell

Hematology & Oncology · Durham, NCNPI 1720161946

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. GSK accounts for 85.0% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for hematology & oncology clinicians in NC, where the typical reported total is $1,703.

$159in general payments, 2019–2025

Across 2 payments — averaging $79.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$135
  • EMD Serono, Inc.$24
$13,243,019in research payments, 2019–2025

Across 133 payments — averaging $99,572 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$10.7M
  • AstraZeneca$2.5M
  • Genentech, Inc.$19K
  • Novartis$5K

What the payments were for

  • Food & beverage$159100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK1$135
EMD Serono, Inc.1$24

How this compares

$159 in reported general payments places this provider in the 15th percentile of 358 hematology & oncology providers in North Carolina.

See all hematology & oncology providers in North Carolina

Other hematology & oncology in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →